Session Chair: Jonathan Zager, MD, Moffitt Cancer Center, Tampa, USA
Lunch Session (non-CME) Sponsored by Castle Biosciences, Inc.
- Tissue based biomarkers of prognosis in malignant melanoma, Jane L. Messina, MD, Moffitt Cancer Center, Tampa, USA
- Surgical management implications of prognostic biomarkers in melanoma, Eddy Hsueh, MD, Professor in the Department of Surgery, Division of General Surgery, at Saint Louis University School of Medicine, St. Louis, USA
- Prognostic biomarkers in the era of melanoma immunotherapy, Jason J. Luke, MD – The University of Chicago Medicine, Chicago, USA